Advances in Cardiovascular Therapy (Technical Insights)


Regular Price: USD 4,950.00

Special Price USD 3,465.00

30% OFF

* Required Fields

Regular Price: USD 4,950.00

Special Price USD 3,465.00


Be the first to review this product

This research service discusses the latest developments in cardiovascular therapy.

Table of Contents

Advances in Cardiovascular Therapy (Technical Insights), Scope and Executive SummaryScope and MethodologyScopeMethodologyExecutive SummaryPrincipal Trends in Cardiovascular TherapySummary of Developments in Cardiovascular TherapiesAdvances in Cardiovascular Therapy (Technical Insights), Technology Adoption Factor AnalysisCardiovascular Therapy--Technology PrimerBackground on Cardiovascular Diseases: Environmental FactorsBiological Factors in Cardiovascular TherapyExternal Environment Assessment for Cardiovascular TherapiesForce Field Analysis for Cardiovascular Therapies—Current ScenarioForce Field Analysis--Improved ScenarioFive Forces Analysis for Cardiovascular TherapiesKey Trends in Cardiovascular TherapiesDrivers and Restraints for Cardiovascular TherapiesChallenges in Cardiovascular TherapiesCurrent Trends in Cardiovascular TherapiesAdvances in Cardiovascular Therapy (Technical Insights), Strategic Assessment of Cardiovascular TherapiesAssessment of Internal Environment for Cardiovascular TherapiesResource and Competency Assessment for Cardiovascular CompaniesAssessment of SWOT for the Cardiovascular Therapeutic IndustryStrategies towards Commercialization and Development of Cardiovascular TherapiesPrevalent Strategies in Commercialization of Cardiovascular TherapiesScenario Analysis for Cardiovascular TherapiesFuture Trends in Cardiovascular TherapiesStakeholder Mapping in Cardiovascular TherapiesProgression of Technologies in Cardiovascular Therapies--Strategy Formulation and Technology GrowthAdvances in Cardiovascular Therapy (Technical Insights), Key Developments in Cardiovascular TherapiesCardiovascular Therapy Developments in CompaniesStem Cell Therapeutics Aids in Restoration of Damaged HeartGene Therapy Enhances Vascular Blood Flow and Manages Cardiac IschemiaAutologous Myoblasts Restore Cardiac Muscle Function after InfarctionStem Cell Therapy Offers Respite against Cardiovascular DiseaseFlavonoid Discovery Platform Promotes Opportunity to Treat Cardiovascular DiseasesControlled Drug Release Technology Offers Scope for Directed Cardiovascular TherapyRNA Interference Offers Hope for Cure of Cardiovascular DiseasesInhibitor Developed for Modifying Development of Atherosclerosis PlaquesPeptide Libraries Offer Scope Enhancing Potential for Drug Discovery for a Plethora of DiseasesPotential Therapeutic Approach Made Possible through Cell SignalingCardiovascular Therapy Developments in UniversitiesEmbryonic Stem Cell Therapy for Cardiomyopathies Demonstrates Positive Impact in Model SystemsIdentification of Arterial Calcification Protein Opens Possibility for Cardiovascular TherapyTreatment with Statins Reduce the Impact of Atherosclerosis and Systemic Lupus ErythematosusAdvances in Cardiovascular Therapy (Technical Insights), Patents and Key Industry ParticipantsPatentsIndustrial PatentsAcademic PatentsKey Industry ParticipantsCompaniesUniversitiesAdvances in Cardiovascular Therapy (Technical Insights), Decision Support DatabaseDecision Support TablesNumber of Biotechnology Companies--World (2004 to 2014)Government R&D Investment in Biotechnology--World (2004 to 2014)Venture Capital Investment in Biotechnology--World (2004 to 2014)

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.